South Korea's ruling party held final negotiations with the opposition party on the budget.Shisi Pharmaceutical Group: Dilalos dispersible tablets (125mg) have obtained the approval of pharmaceutical production registration. Shisi Pharmaceutical Group announced on the Hong Kong Stock Exchange on December 10th that it has obtained the approval of pharmaceutical production registration of Dilalos dispersible tablets (125mg) in National Medical Products Administration, China, which belongs to the fourth category of chemicals and is deemed to have passed the consistency evaluation. Deslorax dispersible tablets are mainly used to treat chronic iron overload caused by frequent blood transfusion in patients with β -thalassemia over two years old, and chronic iron overload in patients with transfusion-independent thalassemia syndrome over 10 years old.With the return of high dividend assets, the market pays attention to the investment value of dividend sector. The Standard & Poor's dividend ETF(562060) rose by 1.07% at midday. By midday on December 10th, the standard & poor's dividend ETF(562060) rose by 1.07%, with a turnover of 20,646,600 yuan. The constituent stocks rose strongly, with Yongxing Materials rising by 3.73%, Aopu Technology rising by 2.12%, Lu 'an Huaneng rising by 2%, Gaoce shares and Jianfa shares rising one after another. In the news, recently, the strong performance of China bond market led to the decline of the yield of 10-year treasury bonds, which fell below the key point of 2.0%, and the dividend assets in the A-share market ushered in an upward trend. Insiders pointed out that the decline in the cost performance of bond allocation is a long-term dimensional reason for supporting the dominance of the dividend sector. With the continuous decline of the yield of 10-year treasury bonds, institutional investors' confirmation of the long-term low interest rate environment will be conducive to the continuous excavation of the value of dividend assets.
Broad-based index products are expected to increase the Y share of personal pension, and personal pension products are expected to expand after the second anniversary of the personal pension system. It is understood that mainstream broad-based index products are expected to increase the personal pension Y share, including Shanghai and Shenzhen 300 Index, CSI 500 Index, CSI A500 Index, GEM Index and other products, which can provide investors with more allocation needs. (SSE)Morgan Stanley published a research report, predicting that Chow Tai Fook's share price will outperform the market index in the same period in the next 30 days with a 70% to 80% chance, pointing out that Politburo meeting of the Chinese Communist Party revealed a strong stimulus policy tone yesterday, indicating that it is necessary to expand domestic demand, and called for supporting measures for housing and stock market stability, hoping for stable asset prices, which will have a positive impact on gold and jewelry consumption. The bank also pointed out that December of each year to February of the following year is usually the traditional peak season for jewelry sales, and Chow Tai Fook's share price has fallen by about 40% this year, which is inferior to the performance of MSCI China Index and Hang Seng Index in the same period. It is expected that the strength and implementation details of the central government's stimulus measures, the pace of inflation and the stability of gold prices in the future will affect whether the company's valuation can be revalued in the market and maintain its "in sync with the market" rating, with a target price of HK$ 8.3.Gaode Infrared sued six former employees and their new owners for infringing on business secrets. The other company: Gaode Infrared announced that there were "false records and false statements". On the evening of December 5, Gaode Infrared announced that the company filed a civil lawsuit against Zhejiang Juexin Microelectronics Co., Ltd. (hereinafter referred to as Juexin Company), Mao Jianhong and six former employees for infringing on the company's business secrets, asking the defendant to pay 200 million yuan in economic losses and other things. On December 6th and 9th, Juexin Company issued statements on the announcement of Gaode Infrared on WeChat WeChat official account "Juexin Microelectronics", claiming that there were "false records, false statements, misleading statements or major omissions" in the above announcement of Gaode Infrared. (per warp net)
Huang Wentao of China CITIC Construction Investment Co., Ltd. and others: It is estimated that deficit ratio will rise to over 4% in 2025, and it is expected that the stock and debt will continue. On December 9th, the Political Bureau of the Central Committee held a meeting to analyze and study the economic work in 2025. Huang Wentao, chief economist of CITIC Jiantou, and Liu Tianyu, macro analyst of CITIC Jiantou, believe that the policy tone of this Politburo meeting is quite proactive, which shows that the central government has made a full assessment and policy reserve for the pressures and risks that may be encountered in economic development next year, which has strongly echoed the expectations of economic entities. Huang Wentao and Liu Tianyu pointed out that GDP growth in the fourth quarter is expected to reach more than 5.2%, achieving the expected goal of annual economic growth of around 5%. On this basis, the annual growth target of about 5% will also be the basic premise of policy discussion in the next few years. Since the fourth quarter of this year, the fiscal policy has been continuously overweight. This time, the fiscal policy is set to be "more active", which indicates that the fiscal policy will expand again. It is estimated that deficit ratio will increase to over 4% in 2025. Both stocks and debts are expected to continue. Unconventional countercyclical adjustment policies not only provide sufficient impetus for the recovery of economic vitality, but also provide strong support for improving expectations and reviving confidence, and provide sufficient source of living water for the capital market. The stock market is expected to continue to strengthen and the risk-free rate of return is expected to continue to decline.Broad-based index products are expected to increase the Y share of personal pension, and personal pension products are expected to expand after the second anniversary of the personal pension system. It is understood that mainstream broad-based index products are expected to increase the personal pension Y share, including Shanghai and Shenzhen 300 Index, CSI 500 Index, CSI A500 Index, GEM Index and other products, which can provide investors with more allocation needs. (SSE)Shisi Pharmaceutical Group: Dilalos dispersible tablets (125mg) have obtained the approval of pharmaceutical production registration. Shisi Pharmaceutical Group announced on the Hong Kong Stock Exchange on December 10th that it has obtained the approval of pharmaceutical production registration of Dilalos dispersible tablets (125mg) in National Medical Products Administration, China, which belongs to the fourth category of chemicals and is deemed to have passed the consistency evaluation. Deslorax dispersible tablets are mainly used to treat chronic iron overload caused by frequent blood transfusion in patients with β -thalassemia over two years old, and chronic iron overload in patients with transfusion-independent thalassemia syndrome over 10 years old.
Strategy guide
12-13
Strategy guide 12-13
Strategy guide
12-13
Strategy guide 12-13